Impact of V.A.C. Veraflo Therapy in Wounds Requiring Debridement Within an Orthopedic Practice

Completed · Not applicable

Conditions studied: Wounds and Injuries

In brief

The objective to this study is to determine the effectiveness of V.A.C.Veraflo negative pressure wound therapy with instillation, when compared to historical controls of V.A.C Therapy without instillation in the management of wounds.

Key facts

Study ID

NCT02266771

Run by

LifeBridge Health

People needed

20

Starts

2014-09-01

Expected to finish

2017-12-01

Last updated by the study team

2018-03-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Signed Informed Consent.
• Patients requiring surgical debridement for wounds with exposed hardware and/or bone, traumatic wounds, dehisced wounds, post-surgical wounds, and pressure ulcers/sores requiring debridement.
• Age: 18 years and above.
• Gender: Male or Female.
• No use of Investigational Agents/Devices on study or within 30 days prior to enrollment.
• Subjects who will be locally available for the next 6 months.

You may not qualify if…

• Wounds involving prosthetic joints.
• Patients who are unable to adhere to scheduled study visits.

Where it is running

• Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore, LifeBridge Health — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.